Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

real-time data

Daiichi Sankyo logo

Daiichi, ArQule cancer drug tivantinib flunks another trial

Fails to meet endpoint in colorectal cancer study

- PMLiVE

Pharma’s reputation declining say patient groups

Pricing policies and a lack of transparency lead list of grievances

- PMLiVE

Janssen’s Zytiga approved for earlier use in Europe

Prostate cancer drug now licensed for use before chemotherapy

EISAI

Eisai’s farletuzumab fails ovarian cancer trial

Unable to improve progression-free survival

- PMLiVE

PatientsLikeMe takes aim at one of world’s rarest diseases

Creates open registry and community for alkaptonuria patients

- PMLiVE

Merck suspends Tredaptive worldwide

Trial demonstrates increased risk of serious adverse events

- PMLiVE

Bayer’s Barbara Jaszewski joins Lundbeck

She is appointed VP, global pricing and market access

- PMLiVE

Streaming Well video series aims to promote liver health

Digital health publisher teams up with the British Liver Trust

Increasing demand for online services from pharma

Study shows patients expect more help managing chronic conditions

European approval for Astellas’ first-in-class bladder drug Betmiga

Will compete with Pfizer's Detrol and Astellas' own Vesicare

- PMLiVE

J&J gets FDA panel backing for canagliflozin

Moves ahead of BMS/AZ’s Forxiga in race for US approval as first in new class of diabetes drug

- PMLiVE

FDA lowers recommended dose for sleeping pills

Says insomnia drugs like Ambien could impair ability to drive in morning

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links